How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

17,325 results for

Anxiety Non-pharmacologic Management

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

17181. Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)

Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD) Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00219349 Recruitment Status : Completed First Posted : September 22, 2005 Results First Posted : May 9, 2012 Last Update Posted : December 19, 2017 Sponsor

2005 Clinical Trials

17182. Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure

Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Calcium-Regulating Hormones and Agents Anti-Anxiety Agents Tranquilizing Agents Central Nervous System Depressants Psychotropic Drugs Hypnotics and Sedatives GABA Modulators GABA Agents Neurotransmitter Agents

2005 Clinical Trials

17183. Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism

Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Paroxetine for Comorbid Social (...) with social anxiety either "very often" or "always." Reports no prior medical alcohol detoxification Willingness to be randomized to the placebo group Willingness to attend 16 weekly medication management visits and one alcohol-related therapy session Liebowitz Social Anxiety Scale Total score (modified version) of at least 60 Endorses drinking at least 15 standard drinks in a typical 30 day period or reports drinking heavily (defined as greater-than-or-equal-to 4 standard drinks on one occasion for women

2005 Clinical Trials

17184. Geodon for the Treatment of Refractory Social Anxiety Disorder

Geodon for the Treatment of Refractory Social Anxiety Disorder Geodon for the Treatment of Refractory Social Anxiety Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Geodon for the Treatment (...) of Refractory Social Anxiety Disorder (SAD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00215150 Recruitment Status : Completed First Posted : September 22, 2005 Results First Posted : May 24, 2013 Last Update Posted : October 31, 2014 Sponsor: Duke University Collaborator: Pfizer Information provided

2005 Clinical Trials

17185. Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.

Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder. Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) : Non-Randomized Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of GABITRIL Treatment (up to 16 mg/Day) in Adults With Generalized Anxiety Disorder. Study Start Date : January 2005 Study Completion Date : December 2006 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Outcome Measures

2005 Clinical Trials

17186. Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms

Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) or nursing female age 18 to 65 years old. Females of childbearing potential must agree to practice an acceptable form of birth control during the time enrolled in the study. Diagnosis of DSM-IV alcohol dependence (DSM-IV checklist). Sub-syndromal mood and/or anxiety symptoms (threshold score of 1 standard deviation above the mean for non-psychiatric population on the anxiety, depression, hostility, or global severity subscales of the SCL-90). Subjects must be able to understand and sign an informed

2005 Clinical Trials

17187. Psychosocial and Medication Treatment for Anxiety in Alcoholism

relaxation therapy (PMR) Other: Placebo medication Phase 2 Phase 3 Detailed Description: Difficulties in anxiety management are frequent causes of relapse to alcohol use. Empirical data support the role of anxiety in alcohol relapse, and both psychosocial and pharmacological treatments for alcohol problems increasingly address the role of negative affect in alcohol-use disorders. Due to the lack of large, well-controlled treatment outcome trials, the optimal treatment (or combination of treatments (...) attempting early abstinence from alcohol. We will address the following four questions: During the course of intervention, is treatment of anxiety disorders with combined treatments of established utility (among non-alcohol-use-disordered patients) superior in managing both return to drinking and anxiety symptoms than either monotherapy, or a fully inactive control treatment? During the follow-up period, will patients who received the combined active treatments fare better in maintaining abstinence

2005 Clinical Trials

17188. A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)

A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD) A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) 3, 2008 Last Verified: April 2008 Additional relevant MeSH terms: Layout table for MeSH terms Disease Anxiety Disorders Pathologic Processes Mental Disorders Naluzotan Serotonin 5-HT1 Receptor Agonists Serotonin Receptor Agonists Serotonin Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs

2005 Clinical Trials

17189. Study To Evaluate The Effects Of Gabitrilâ„¢ In Patients With Social Anxiety Disorder

Study To Evaluate The Effects Of Gabitrilâ„¢ In Patients With Social Anxiety Disorder Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) for eligibility information Ages Eligible for Study: 18 Years to 65 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Primary diagnosis of SAD CGI (S) ≥ 4 at screen LSAS ≥ 50 at baseline Covi Anxiety Scale score greater than the Raskin depression Scale total score at screen Exclusion Criteria: Non-responsive to adequate trials of two or more treatment medications, if previously treated for SAD. HAM-D ≥15 or a score of >2 on Item 1 at baseline

2005 Clinical Trials

17190. Treatment of Citalopram for Anxiety Disorders Following a Traumatic Brain Injury

Treatment of Citalopram for Anxiety Disorders Following a Traumatic Brain Injury Treatment of Citalopram for Anxiety Disorders Following a Traumatic Brain Injury - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) evidence of iii. trauma (MRI/CT hemorrhage/contusion) Traumatic brain injury with recovery to a Rancho los Amigos level 7 or 8 (alert and oriented). Meet criteria for DSM IV diagnosis Anxiety Disorder Due to a General Medical Condition. The symptoms of the anxiety disorder are not being controlled adequately with or without treatment at the time of referral. Military or Veteran beneficiary Men and non-pregnant/non-breastfeeding females Aged 18-65 Exclusion Criteria: Severe prior neurologic

2005 Clinical Trials

17191. Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder

Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) -IV criteria for Social Anxiety Disorder Exclusion Criteria: Pregnant or breastfeeding Narrow angle glaucoma Any uncontrolled medical condition or any medical condition which would represent a contraindication to atomoxetine (Strattera) pharmacotherapy (e.g., hepatic insufficiency, untreated hypertension, untreated cardiovascular or cerebrovascular disease) Any concomitant non-psychotropic medications that the physician determines are a contraindication to atomoxetine (Strattera) pharmacotherapy

2005 Clinical Trials

17192. A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI’s, and SNRI’s Treatment in Major Depression With Anxiety

A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI’s, and SNRI’s Treatment in Major Depression With Anxiety A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer (...) Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors Treatment in Major Depression With Comorbid Anxiety Symptoms Study Start Date : November 2003 Study Completion Date : April 2005 Resource links provided by the National Library of Medicine related topics: related topics: available for: Arms and Interventions Go to Outcome Measures Go to Primary Outcome Measures : To compare the efficacy of quetiapine versus placebo over 8 weeks as an adjunctive agent for unipolar non-psychotic adult outpatients

2005 Clinical Trials

17193. Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder

Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) dependence. Patients who have received non-pharmacologic, somatic treatments for psychiatric disease Patients who have initiated, stopped, or changed the frequency or nature of psychotherapy within 3 months prior to screening. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov

2005 Clinical Trials

17194. MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00252174 Recruitment Status : Terminated (Lack of funds and insufficient patient population for study enrollment.) First Posted : November 11, 2005 Results First Posted : May

2005 Clinical Trials

17195. Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder

Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00235508 Recruitment Status : Completed First Posted : October 10, 2005 Last Update Posted : February 22, 2012 Sponsor: Sunovion Information provided by (Responsible

2005 Clinical Trials

17196. Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder

Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) Pharmaceutical Industries ( Cephalon ) Study Details Study Description Go to Brief Summary: To assess the long-term safety and tolerability of tiagabine treatment in patients with generalized anxiety disorder (GAD). Condition or disease Intervention/treatment Phase General Anxiety Disorder Drug: GABITRIL (tiagabine hydrochloride; CEP-6671) Phase 3 Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Allocation: Non-Randomized Intervention Model: Single Group

2005 Clinical Trials

17197. A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00236054 Recruitment Status : Completed First Posted : October 12, 2005

2005 Clinical Trials

17198. A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) , 2005 Last Update Posted: May 9, 2014 Last Verified: May 2014 Additional relevant MeSH terms: Layout table for MeSH terms Disease Anxiety Disorders Pathologic Processes Mental Disorders Tiagabine Anticonvulsants GABA Uptake Inhibitors Neurotransmitter Uptake Inhibitors Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action GABA Agents Neurotransmitter Agents Physiological Effects of Drugs

2005 Clinical Trials

17199. A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) 2014 Additional relevant MeSH terms: Layout table for MeSH terms Disease Anxiety Disorders Pathologic Processes Mental Disorders Tiagabine Anticonvulsants GABA Uptake Inhibitors Neurotransmitter Uptake Inhibitors Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action GABA Agents Neurotransmitter Agents Physiological Effects of Drugs

2005 Clinical Trials

17200. Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) provided by Wyeth is now a wholly owned subsidiary of Pfizer: Social Anxiety Children Disorders Additional relevant MeSH terms: Layout table for MeSH terms Disease Anxiety Disorders Phobia, Social Pathologic Processes Mental Disorders Phobic Disorders Venlafaxine Hydrochloride Serotonin and Noradrenaline Reuptake Inhibitors Neurotransmitter Uptake Inhibitors Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Neurotransmitter Agents Physiological Effects of Drugs Antidepressive

2005 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>